News | Radiation Oncology | July 13, 2015

Company's RegistrationQX platform provides automated, quantitative assessment of DIR to eliminate inter-user variability

Mirada Medical, deformable image registration, DIR, QA, RegistrationQX, AAPM

July 13, 2015 - Mirada Medical and collaborators from the University Medical Center, Groningen, The Netherlands, will present new research on quality assurance of deformable image registration (DIR) at the annual meeting of the American Association of Medical Physicists (AAPM). Accurate definition of targets and critical structures is essential for the planning and delivery of radiation therapy and radiosurgery. DIR is increasingly utilized during treatment planning to aid in this process.

A critical step in deploying DIR in the clinic is quality assurance of the result. To date, this has been typically performed qualitatively using tools such as fusion overlays and inspection of the deformation field, requiring a user experienced with DIR, patient anatomy and the clinical context. Such an approach is subjective and can lead to significant inter-user variability. Existing quantitative tools such as measuring target registration error and dice overlap of structures are practical for commissioning and research but are often too labor-intensive for clinical use.

Mirada Medical and collaborators will be introducing RegistrationQX, a novel technique to overcome these limitations. RegistrationQX uses a set of quantitative measurements of the deformation quality, numerical robustness and matching to assist the user in assessing the quality of a DIR result. With the release of RegistrationQX, clinical staff will be able to augment their visual DIR quality assurance with an automatically generated quantitative report. The original research compares the quantitative scores produced by RegistrationQX with grading scores produced by experts with significant experience in using DIR clinically on 27 head and neck patients. Good correlation (0.86) was observed between the automatic and manual scores indicating that the quantitative scores reflected the opinions of the experts.

RegistrationQX and this study form part of Mirada's Registration Assurance program, a comprehensive program for ensuring DIR quality and continuous improvement through rigorous scientific validation of technology, education, comprehensive QC tools and a commitment to ongoing development and support. The registration workflows used in the study are all available in the new releases of Mirada RTx and Mirada Workflow Box.

For more information: www.mirada-medical.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
News | Population Health

April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...

Time April 04, 2024
arrow
Subscribe Now